Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Colorado State University
Zagazig University
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of Salamanca
AC Camargo Cancer Center
University Health Network, Toronto
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
IRCCS San Raffaele
Arab American University (Palestine)
Tempus AI
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Intensity Therapeutics, Inc.
Taproot Health
VitaMed Research LLC
National Institutes of Health Clinical Center (CC)
Sanguine Biosciences
Stanford University
Biologics & Biosimilars Collective Intelligence Consortium
Eastern Cooperative Oncology Group
Case Comprehensive Cancer Center
Genzada Pharmaceuticals USA, Inc.
Blue Note Therapeutics
Weprom
University Health Network, Toronto
Institut BergoniƩ
Case Comprehensive Cancer Center
University of Wisconsin, Madison
National Institutes of Health Clinical Center (CC)
University of Southern California
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
Amgen
National Institutes of Health Clinical Center (CC)
European Organisation for Research and Treatment of Cancer - EORTC
Hospital Sao Rafael
Wake Forest University Health Sciences
National Cancer Center, Korea
Tianjin Medical University Cancer Institute and Hospital
University of Washington
Memorial Sloan Kettering Cancer Center
Stanford University
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)